{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:21:24Z","timestamp":1793859684397,"version":"4.6.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,5,10]],"date-time":"2012-05-10T00:00:00Z","timestamp":1336608000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1756-0500-5-225","type":"journal-article","created":{"date-parts":[[2012,5,10]],"date-time":"2012-05-10T14:26:44Z","timestamp":1336660004000},"source":"Crossref","is-referenced-by-count":41,"title":["Relatively low primary drug resistant tuberculosis in southwestern Ethiopia"],"prefix":"10.1186","volume":"5","author":[{"given":"Gemeda","family":"Abebe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketema","family":"Abdissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alemseged","family":"Abdissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig","family":"Apers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mulualem","family":"Agonafir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bouke C","family":"de-Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Colebunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,5,10]]},"reference":[{"key":"1638_CR1","volume-title":"WHO Report 2011. Global tuberculosis control 2011","author":"World Health Organization","year":"2011","unstructured":"World Health Organization: WHO Report 2011. Global tuberculosis control 2011. 2011, Geneva: World Health Organization"},{"key":"1638_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1574-695X.2008.00400.x","volume":"53","author":"A Jain","year":"2008","unstructured":"Jain A, Mondal R: Extensively drug-resistant tuberculosis: current challenges and threats. FEMS Immunol Med Microbiol. 2008, 53: 145-150. 10.1111\/j.1574-695X.2008.00400.x.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"1638_CR3","volume-title":"Anti-tuberculosis drug resistance in the world. Fourth global report. WHO\/HTM\/TB\/2008.394","author":"World Health Organization, IUATLD","year":"2008","unstructured":"World Health Organization, IUATLD: Anti-tuberculosis drug resistance in the world. Fourth global report. WHO\/HTM\/TB\/2008.394. 2008, Geneva: World Health Organization"},{"key":"1638_CR4","first-page":"149","volume":"70","author":"P Sudre","year":"1992","unstructured":"Sudre P, ten Dam G, Kochi A: Tuberculosis: a global overview of the situation today. Bull World Health Organ. 1992, 70: 149-159.","journal-title":"Bull World Health Organ"},{"key":"1638_CR5","first-page":"367","volume":"46","author":"D Asmamaw","year":"2008","unstructured":"Asmamaw D, Seyoum B, Makonnen E, Atsebeha H, Woldemeskel D, Yamuah L, Addus H, Aseffa A: Primary drug resistance in newly diagnosed smear positive tuberculosis patients in Addis Ababa, Ethiopia. Ethiop Med J. 2008, 46: 367-374.","journal-title":"Ethiop Med J"},{"key":"1638_CR6","first-page":"219","volume":"46","author":"DW Meskel","year":"2008","unstructured":"Meskel DW, Abate G, Lakew M, Goshu S, Aseffa A: Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital. Ethiop Med J. 2008, 46: 219-225.","journal-title":"Ethiop Med J"},{"key":"1638_CR7","first-page":"580","volume":"2","author":"G Abate","year":"1998","unstructured":"Abate G, Miorner H, Ahmed O, Hoffner SE: Drug resistance in Mycobacterium tuberculosis strains isolated from re-treatment cases of pulmonary tuberculosis in Ethiopia: susceptibility to first-line and alternative drugs. Int J Tuberc Lung Dis. 1998, 2: 580-584.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1638_CR8","first-page":"158","volume":"74","author":"G Mitike","year":"1997","unstructured":"Mitike G, Kebede D, Yeneneh H: Prevalence of antituberculosis drug resistance in Harar Tuberculosis Centre, Ethiopia. East Afr Med J. 1997, 74: 158-161.","journal-title":"East Afr Med J"},{"key":"1638_CR9","first-page":"1259","volume":"14","author":"M Agonafir","year":"2010","unstructured":"Agonafir M, Lemma E, Wolde-Meskel D, Goshu S, Santhanam A, Girmachew F, Demissie D, Getahun M, Gebeyehu M, van Soolingen D: Phenotypic and genotypic analysis of multidrug-resistant tuberculosis in Ethiopia. Int J Tuberc Lung Dis. 2010, 14: 1259-1265.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1638_CR10","volume-title":"Guidance on provider initiated HIV testing and counseling in health facilities","author":"World Health Organization","year":"2007","unstructured":"World Health Organization: Guidance on provider initiated HIV testing and counseling in health facilities. 2007, Geneva: World Health Organization"},{"key":"1638_CR11","volume-title":"WHO\/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Guidelines for surveillance of drug resistance in tuberculosis","author":"World Health Organization","year":"2003","unstructured":"World Health Organization: WHO\/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Guidelines for surveillance of drug resistance in tuberculosis. 2003, Geneva: WHO, WHO\/CDS\/TB\/2003.320-WHO\/CDS\/CSR\/RMD\/2003.3, 2","edition":"2"},{"key":"1638_CR12","volume-title":"Public health mycobacteriology: A guide for the level III laboratory. U. S. department of Health and Human Services. Centres for Disease Control, Atlanta, Ga. Centres for Disease Control","author":"P Kent","year":"1985","unstructured":"Kent P, G K: Public health mycobacteriology: A guide for the level III laboratory. U. S. department of Health and Human Services. Centres for Disease Control, Atlanta, Ga. Centres for Disease Control. 1985, Atlanta: Ga"},{"key":"1638_CR13","volume-title":"MGITTMProcedure Mannual","author":"SH Siddiqi","year":"2006","unstructured":"Siddiqi SH, R\u00fcsch-Gerdes S: MGITTMProcedure Mannual. 2006, Geneva, Switzerland: Foundation for Innovative New Diagnostics"},{"key":"1638_CR14","first-page":"11","volume":"15","author":"M Gebeyehu","year":"2001","unstructured":"Gebeyehu M, Lemma E, Eyob G: Prevalence of drug resistant tuberculosis in Arsi Zone, Ethiopia. Eth J Health Dev. 2001, 15: 11-16.","journal-title":"Eth J Health Dev"},{"key":"1638_CR15","first-page":"203","volume":"48","author":"M Mekonen","year":"2010","unstructured":"Mekonen M, Abate E, Aseffa A, Anagaw B, Elias D, Hailu E, Idh J, Moges F, Wolde-Amanuel Y, Asrat D, et al: Identification of drug susceptibility pattern and mycobacterial species in sputum smear positive pulmonary tuberculosis patients with and without HIV co-infection in north west Ethiopia. Ethiop Med J. 2010, 48: 203-210.","journal-title":"Ethiop Med J"},{"key":"1638_CR16","first-page":"282","volume":"94","author":"LM Apers","year":"2004","unstructured":"Apers LM, Chihota V: Susceptibility of a series of routine sputum samples for antituberculosis chemotherapy in Gweru. Zimbabwe. S Afr Med J. 2004, 94: 282-","journal-title":"Zimbabwe. S Afr Med J"},{"key":"1638_CR17","doi-asserted-by":"publisher","first-page":"e16130","DOI":"10.1371\/journal.pone.0016130","volume":"6","author":"D Lukoye","year":"2008","unstructured":"Lukoye D, Cobelens FG, Ezati N, Kirimunda S, Adatu FE, Lule JK, Nuwaha F, Joloba ML: Rates of anti-tuberculosis drug resistance in Kampala-Uganda are low and not associated with HIV infection. PLoS One. 2008, 6: e16130-","journal-title":"PLoS One"},{"key":"1638_CR18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1471-2334-11-94","volume":"11","author":"JP Assam-Assam","year":"2011","unstructured":"Assam-Assam JP, Penlap VB, Cho-Ngwa F, Tedom JC, Ane-Anyangwe I, Titanji VP: Mycobacterium tuberculosis complex drug resistance pattern and identification of species causing tuberculosis in the West and Centre regions of Cameroon. BMC Infect Dis. 2011, 11: 94-10.1186\/1471-2334-11-94.","journal-title":"BMC Infect Dis"},{"key":"1638_CR19","doi-asserted-by":"publisher","first-page":"e7954","DOI":"10.1371\/journal.pone.0007954","volume":"4","author":"F Matthys","year":"2009","unstructured":"Matthys F, Rigouts L, Sizaire V, Vezhnina N, Lecoq M, Golubeva V, Portaels F, Van der Stuyft P, Kimerling M: Outcomes after chemotherapy with WHO category II regimen in a population with high prevalence of drug resistant tuberculosis. PLoS One. 2009, 4: e7954-10.1371\/journal.pone.0007954.","journal-title":"PLoS One"},{"key":"1638_CR20","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3201\/eid0705.010512","volume":"7","author":"P Bifani","year":"2001","unstructured":"Bifani P, Mathema B, Campo M, Moghazeh S, Nivin B, Shashkina E, Driscoll J, Munsiff SS, Frothingham R, Kreiswirth BN: Molecular identification of streptomycin monoresistant Mycobacterium tuberculosis related to multidrug-resistant W strain. Emerg Infect Dis. 2001, 7: 842-848.","journal-title":"Emerg Infect Dis"},{"key":"1638_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1473-3099(09)70041-6","volume":"9","author":"EW Orenstein","year":"2009","unstructured":"Orenstein EW, Basu S, Shah NS, Andrews JR, Friedland GH, Moll AP, Gandhi NR, Galvani AP: Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infect Dis. 2009, 9: 153-161. 10.1016\/S1473-3099(09)70041-6.","journal-title":"Lancet Infect Dis"},{"key":"1638_CR22","doi-asserted-by":"publisher","first-page":"e1126","DOI":"10.1371\/journal.pone.0001126","volume":"2","author":"HS Cox","year":"2007","unstructured":"Cox HS, Kalon S, Allamuratova S, Sizaire V, Tigay ZN, Rusch-Gerdes S, Karimovich HA, Kebede Y, Mills C: Multidrug-resistant tuberculosis treatment outcomes in Karakalpakstan, Uzbekistan: treatment complexity and XDR-TB among treatment failures. PLoS One. 2007, 2: e1126-10.1371\/journal.pone.0001126.","journal-title":"PLoS One"},{"key":"1638_CR23","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.3201\/eid1209.051618","volume":"12","author":"E Nathanson","year":"2006","unstructured":"Nathanson E, Lambregts-van Weezenbeek C, Rich ML, Gupta R, Bayona J, Blondal K, Caminero JA, Cegielski JP, Danilovits M, Espinal MA, et al: Multidrug-resistant tuberculosis management in resource-limited settings. Emerg Infect Dis. 2006, 12: 1389-1397. 10.3201\/eid1209.051618.","journal-title":"Emerg Infect Dis"},{"key":"1638_CR24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1756-0500-5-44","volume":"5","author":"C Muchwa","year":"2012","unstructured":"Muchwa C, Akol J, Etwom A, Morgan K, Orikiriza P, Mumbowa F, Odong PR, Kateete DP, Eisenach KD, Joloba ML: Evaluation of Capilia TB assay for rapid identification of Mycobacterium tuberculosis complex in BACTEC MGIT 960 and BACTEC 9120 blood cultures. BMC Res Notes. 2012, 5: 44-10.1186\/1756-0500-5-44.","journal-title":"BMC Res Notes"},{"key":"1638_CR25","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.diagmicrobio.2007.06.010","volume":"59","author":"JY Wang","year":"2007","unstructured":"Wang JY, Lee LN, Lai HC, Hsu HL, Jan IS, Yu CJ, Hsueh PR, Yang PC: Performance assessment of the Capilia TB assay and the BD ProbeTec ET system for rapid culture confirmation of Mycobacterium tuberculosis. Diagn Microbiol Infect Dis. 2007, 59: 395-399. 10.1016\/j.diagmicrobio.2007.06.010.","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-5-225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1756-0500-5-225\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-5-225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T21:37:23Z","timestamp":1548106643000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/1756-0500-5-225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,10]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1638"],"URL":"https:\/\/doi.org\/10.1186\/1756-0500-5-225","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,10]]},"article-number":"225"}}